Eagle Pharmaceuticals Revenue and Competitors

Woodcliff Lake, NJ USA

Location

$12.3M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Eagle Pharmaceuticals's estimated annual revenue is currently $43.5M per year.(i)
  • Eagle Pharmaceuticals's estimated revenue per employee is $251,250
  • Eagle Pharmaceuticals's total funding is $12.3M.

Employee Data

  • Eagle Pharmaceuticals has 173 Employees.(i)
  • Eagle Pharmaceuticals grew their employee count by 26% last year.

Eagle Pharmaceuticals's People

NameTitleEmail/Phone
1
EVP, General Counsel & Chief Compliance OfficerReveal Email/Phone
2
Head Commercial for Acute Care/HospitalReveal Email/Phone
3
VP, Market Access, OncologyReveal Email/Phone
4
Head Commercial for Acute Care/HospitalReveal Email/Phone
5
EVP, Oncology Business DevelopmentReveal Email/Phone
6
VP Pharmaceutical SciencesReveal Email/Phone
7
EVP Oncology & Acute Care MarketingReveal Email/Phone
8
SVP, Pharmaceutical DevelopmentReveal Email/Phone
9
SVP, Oncology AccountsReveal Email/Phone
10
SVP, Hospital Sales and MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Eagle Pharmaceuticals?

Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway. Our business model is to develop proprietary innovations to FDA-approved, injectable drugs, which we refer to as branded listed drugs, that offer longer commercial duration provided by orphan drug exclusivity, new intellectual property protection, and/or three years of non-patent regulatory exclusivity as provided under the Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch Waxman Act.

keywords:N/A

$12.3M

Total Funding

173

Number of Employees

$43.5M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Eagle Pharmaceuticals News

2022-04-20 - Eagle Pharmaceuticals to Host First Quarter 2022 Financial Results on May 9, 2022 - Benzinga

About Eagle Pharmaceuticals, Inc. Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and...

2022-04-19 - EAGLE PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

EAGLE PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K). Link copied. 04/27/2022 | 06:14am...

2022-04-13 - Eagle Pharmaceuticals Reaches Settlement Agreement with Hospira Related to BENDEKA® (bendamustine hydrochloride) until January 17, 2028

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.1M2836%N/A
#2
$131M422-1%N/A
#3
$100.2M553-3%N/A
#4
$367M7498%N/A
#5
$1216M26327%N/A